Ravelous is the crypto ecommerce marketplace that lets users sell their stuff online for crypto. Sellers can accept many types of payments from buyers, and withdraw your balance in the token of their choosing. Buyers who do not have the currency the sellers prefer can exchange their coins for RAVE tokens which used for payment. The RAVE tokens can also be traded for other coins, and will have a value backed by the crypto-marketplace and the RAVE treasury that will increase over time as the treasury grows in value.

Bitindia is a cryptocurrency exchange and wallet for the streets of India. BitIndia will be bringing an open source platform which empowers the users to have secure transactions and hold the private keys of the cryptocurrencies on the Blockchain nodes. The BitIndia wallet will transform the current structure and concept of crypto wallets. While BitIndia wallets aims to make blockchain mainstream in India, the BitIndia exchange will let any layman to buy, sell and understand cryptocurrencies in the easiest and fastest scam free platform ever designed. The BitIndia wallet aspire to become an essential part of daily routine activities such as buying groceries, paying bills or dining at a restaurant; while using cryptocurrencies as a medium of exchange. BitIndia exchange will let its users to trade on essential cryptocurrencies with the Indian currency. This will not only promote various cryptocurrencies in India but also promote blockchain technology globally.

Lohn is a widely spread contractual form in various industrial fields of international cooperation relations, especially in the industry of clothing, footwear, leather, furniture, software and hardware, pharmaceutical, metal working, metallurgical, machine tools, automotive, automation, machine building industry, electronics and appliance industry, food and beverage industry, petrochemical industry. The lohn (processing economy) has been and will be a solution to produce goods at reasonable and high-quality prices through the efficient use of labor and cheap raw materials in emerging economies. It is also a business model that creates economic and social progress across the world bringing together markets with productive resources and capabilities. The trading platform developed by the lohncontrol project will create global opportunities for small and medium-sized businesses that are responsible for generating 60% of GDP. It will give them a visibility that they do not have at this time and will encourage the development of direct business between them. This means low manufacturing costs and greater adaptation to market demands. Those who will win at the end of this interaction will be consumers who will get good products at realistic prices.

Safein is a blockchain-based single sign-on identity management platform ensuring security, comfort and trust for our customers. With Safein, users can easily demonstrate their true identity online where needed and control the extent of their personal data given out to various service providers.

A blockchain-based integrative data marketplace for the global renewable energy industry. The REDi Infranet will empower various renewable energy producers, consumers, and industry experts to consolidate, verify, and distribute data in the search for improved productivity and efficiency towards true sustainability.

Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.